Results 111 to 120 of about 343 (127)
Some of the next articles are maybe not open access.

A comparison of the EQ-5D-5L and the SF-6Dv2 among patients with hypertrophic obstructive cardiomyopathy

2023
Abstract Background Hypertrophic obstructive cardiomyopathy (HOCM) is a serious and complex chronic disease severely affecting patients’ daily lives and health-related quality of life (HRQoL). The psychometric performance of generic preference-based instruments has not been compared in Chinese ...
Xiaoyu Wang   +4 more
openaire   +1 more source

Mapping KDQOL-36 Onto EQ-5D-5L and SF-6Dv2 in Patients Undergoing Dialysis in China

open access: yesValue in Health Regional Issues
To develop mapping algorithms based on Kidney Disease Quality of Life-36 (KDQOL-36) scores to the EQ-5D-5L and SF-6Dv2 utility values among dialysis patients in China.We used data from a cross-sectional multicenter survey in China to map the KDQOL-36 to the EQ-5D-5L and SF-6Dv2.
Zeyuan, Chen, Li, Yang, Ye, Zhang
exaly   +3 more sources

Comparing the performance of the EQ-5D-5L with two versions of the SF-6Dv2 in patients with breast cancer

Health Services and Outcomes Research Methodology, 2020
The EQ-5D-5L and two versions of the SF-6D version 2 (i.e., SF-6Dv2ind-10 that is derived from 10 items of the SF-36v2, and SF-6Dv2SF-36 that is derived from its combination with the full SF-36v2) are used to drive utilities. The study was prospected to compare the performance of these instruments in breast cancer patients.
Azin Nahvijou   +2 more
openaire   +1 more source

Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China

Applied Health Economics and Health Policy
There are limited studies comparing the health utility values of EQ-5D-5L and SF-6Dv2 within the same patient cohorts. The widespread transmission and recurring infections associated with Omicron variants amid the COVID-19 pandemic have resulted in substantial health detriments and increased utilisation of health care resources.
Ningxin Ding   +4 more
openaire   +2 more sources

Quality-Adjusted Life Expectancy Norms Based on the EQ-5D-5L and SF-6Dv2 for China

Applied Health Economics and Health Policy
Quality-adjusted life expectancy (QALE) norms reflect the normative profiles or reference data of QALE of the general population and provide a meaningful anchor for comparison to inform healthcare decision-making. This study aimed to develop the QALE norms for the Chinese population by using a representative dataset of health utility values collected ...
Shitong Xie   +3 more
openaire   +2 more sources

Mapping IWQOL-Lite onto EQ-5D-5L and SF-6Dv2 among overweight and obese population in China

Quality of Life Research
To develop the mapping functions from the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) scores onto the EQ-5D-5L and SF-6Dv2 utility values among the overweight and obese population in China.A representative sample of the overweight and obese population in China stratified by age, sex, body mass index (BMI), and area of residence was collected ...
Jing Wu
exaly   +3 more sources

Optimizing presentation formats for SF-6Dv2 health status valuation: a qualitative study using cognitive interviews

Quality of Life Research
The SF-6Dv2 health status valuation using the discrete choice experiment (DCE) method requires effective presentation strategies to improve respondents' overall understanding and reduce bias, particularly in online surveys. This study aimed to determine the optimal presentation formats for DCE choice tasks through qualitative interviews.We conducted ...
Jahyun Cho   +3 more
openaire   +2 more sources

HTA163 Development of SF-6Dv2 Health Utility Weights in the United States

Value in Health, 2022
R Rendas-Baum   +5 more
openaire   +1 more source

Comparing EQ-5D-5L and SF-6Dv2 utilities with QLU-C10D utilities in hematologic cancer patients

The European Journal of Health Economics
To compare the measurement properties between EQ-5D-5L/SF-6Dv2 and QLU-C10D utilities, and to assess the implications of their adoption in QALY estimation in hematologic cancer patients.Longitudinal data of Chinese lymphoma and myeloma patients were adopted.
Tiantian Zhang   +5 more
openaire   +2 more sources

Exploring the consistency of the SF-6Dv2 in a breast cancer population

Expert Review of Pharmacoeconomics and Outcomes Research, 2021
Hosein Ameri   +2 more
exaly  

Home - About - Disclaimer - Privacy